AstraZeneca Broadens US Growth Push
AstraZeneca CFO Aradhana Sarin discusses how the pharmaceutical company is broadening its US shareholder base and plans to generate $80 Billion in revenue by 2030. She speaks with Bloomberg's Katie Greifeld.
More from Australia
Argenica’s US stroke trial stalls as FDA demands rat brain study
Echo IQ shares sink 42% as FDA upholds rejection
Australian Vintage names new CFO, starting January 2027
ASIC warns on QUFC Exchange, removes 20+ websites
WA Government commits $4m to life sciences hub
Count Financial wins Federal Court appeal in class action over advisor commissions